Free Trial
CVE:BRM

BioRem (BRM) Stock Price, News & Analysis

BioRem logo
C$3.39 0.00 (0.00%)
As of 03:38 PM Eastern

About BioRem Stock (CVE:BRM)

Advanced

Key Stats

Today's Range
C$3.33
C$3.39
50-Day Range
C$2.41
C$3.30
52-Week Range
C$1.67
C$3.40
Volume
9,229 shs
Average Volume
26,530 shs
Market Capitalization
C$54.70 million
P/E Ratio
13.04
Dividend Yield
6.47%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioRem and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BRM Stock News Headlines

Biorem Reports $65.3 Million Order Backlog
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
BRM:CA BioRem Inc.
See More Headlines

BRM Stock Analysis - Frequently Asked Questions

BioRem's stock was trading at C$2.70 at the beginning of the year. Since then, BRM shares have increased by 25.6% and is now trading at C$3.39.

BioRem Inc. (CVE:BRM) released its quarterly earnings results on Wednesday, November, 6th. The company reported $0.12 earnings per share for the quarter. BioRem had a trailing twelve-month return on equity of 39.51% and a net margin of 11.37%.

Shares of BRM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioRem investors own include TVA Group (TVA.B), Questor Technology (QST), AutoZone (AZO), Cadence Design Systems (CDNS), FormFactor (FORM), Intel (INTC) and

Company Calendar

Last Earnings
11/06/2024
Today
5/05/2026

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Pollution & Treatment Controls
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:BRM
CIK
N/A
Fax
N/A
Employees
34,300
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.26
Trailing P/E Ratio
13.04
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$5.40 million
Net Margins
11.37%
Pretax Margin
N/A
Return on Equity
39.51%
Return on Assets
14.61%

Debt

Debt-to-Equity Ratio
18.97
Current Ratio
1.85
Quick Ratio
1.08

Sales & Book Value

Annual Sales
C$42.36 million
Price / Sales
1.29
Cash Flow
C$0.92 per share
Price / Cash Flow
3.70
Book Value
C$0.93 per share
Price / Book
3.66

Miscellaneous

Outstanding Shares
16,135,000
Free Float
N/A
Market Cap
C$54.70 million
Optionable
Not Optionable
Beta
1.01
The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (CVE:BRM) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners